Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Ameratunga M, Brana I, Bono P, Postel-Vinay S, et al. First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours. Br J Cancer 2020;123:1730-1736.
PMID: 32989226


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016